Aging
Navigate
Back to articleFigure 3B(4 of 11)
100%
Figure 3B
Figure 3B.Wound healing assays were performed. The amount of migrating cells of sFlt1 (1.5 ml of concentrated conditioned medium) plus low-dose doxorubicin group were much lower than control. Magnification, 200×. Picture of one representative experiment of 3 is shown. Data from 3 independent experiments are shown. *p < 0.05, vs sFlt1 plus low-dose doxorubicin group.
Figure 3B — Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer | Aging